Xbrane Biopharma och Redeye bjuder in till bolagspresentation den 7 mars i Malmö
05 mars 2019 06h30 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pressmeddelande2019-03-05 Xbrane...
Xbrane Biopharma and Redeye invites to a company presentation in Malmö 7th of March.
05 mars 2019 06h30 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release2019-03-05 Xbrane...
Styrelsen i Xbrane har beslutat om fullt garanterad företrädesemission om högst cirka 60 MSEK
28 févr. 2019 16h32 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pressmeddelande...
The Board of Directors of Xbrane has resolved on a fully guaranteed rights issue of up to approximately SEK 60 million
28 févr. 2019 16h32 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release28 February 2019 ...
Xbrane Biopharma publicerar bokslutskommuniké för 2018
22 févr. 2019 02h00 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pressmeddelande2019-02-22 Xbrane...
Xbrane Biopharma releases Year-end report for 2018
22 févr. 2019 02h00 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release2019-02-22 Xbrane...
Xbrane Biopharma AB: Alessandro Sidoli och Saeid Esmaeilzadeh kommer inte att ställa upp för omval 2019
21 févr. 2019 10h20 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pressmeddelande2019-02-21 Xbrane...
Xbrane Biopharma AB: Alessandro Sidoli and Saeid Esmaeilzadeh decline re-election for 2019
21 févr. 2019 10h20 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release2019-02-21 Xbrane...
Xbrane Biopharma AB tidigarelägger bokslutskommunikén avseende räkenskapsåret 2018
20 févr. 2019 09h30 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Pressmeddelande2019-02-20 Xbrane...
Xbrane Biopharma AB advances the release of the Year-end report for 2018
20 févr. 2019 09h30 HE
|
Xbrane Biopharma AB
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Press release2019-02-20 Xbrane...